MRPL39

MRPL39 encodes a protein component of the large subunit (LSU) of the mitochondrial ribosome (PMID:24206665, PMID:37133451). Studies of the yeast ortholog place its incorporation at a late step of mitoribosome assembly: in the absence of the DEAD-box RNA helicase Mrh4, an on-pathway assembly intermediate accumulates that lacks both Mrpl16 and Mrpl39, indicating that Mrh4-mediated rRNA remodeling licenses Mrpl39 addition during LSU maturation (PMID:24206665). In humans, biallelic pathogenic variants in MRPL39 cause multisystem mitochondrial disease; quantitative proteomics of patient fibroblasts shows a selective decrease in LSU proteins but not small-subunit proteins, demonstrating that loss of MRPL39 specifically destabilizes the large mitoribosomal subunit and thereby impairs synthesis of the 13 mtDNA-encoded OXPHOS subunits, with phenotypes ranging from lethal infantile Leigh syndrome to milder adult-onset disease (PMID:37133451). Early sequence and structural modeling noted similarity to threonyl-tRNA synthetases and a candidate RNA-binding site, and identified a heart-specific splice variant predicted to alter RNA binding (PMID:11167009), but these features remain computational and uncharacterized biochemically in the available corpus.

1. 2000 Low

   Established MRPL39 as a mitochondrial large-subunit ribosomal protein and raised the first structural hypotheses about its function, framing it as a potential RNA-binding component with tissue-specific isoform regulation.

   Evidence EST/cDNA library screening, sequencing, and 3D structural modeling identifying a 338-aa protein and a heart-specific 353-aa splice variant

   PMID:11167009

   Open questions at the time

   • RNA binding and the predicted threonyl-tRNA-synthetase-like fold were inferred from modeling only, not biochemically validated
   • Functional consequence of the heart-specific splice variant was not tested
   • No direct demonstration of incorporation into the mitoribosome
2. 2013 Medium

   Defined when MRPL39 joins the mitoribosome by showing its incorporation is a late, helicase-dependent step of LSU assembly, distinguishing it from early-assembling components.

   Evidence Mrh4 genetic deletion in S. cerevisiae with sucrose-gradient sedimentation and mass spectrometry of accumulated assembly intermediates

   PMID:24206665

   Open questions at the time

   • Demonstrated in the yeast ortholog; late-assembly timing not directly confirmed in human cells
   • Does not define the specific molecular contacts MRPL39 makes within the mature LSU
   • Mechanism of rRNA remodeling that permits MRPL39 addition not resolved at structural level
3. 2023 High

   Connected MRPL39 loss-of-function to human disease and established its mechanism: specific LSU destabilization that selectively impairs mtDNA-encoded OXPHOS subunit synthesis.

   Evidence Quantitative proteomics (Relative Complex Abundance), exome/genome sequencing, and transcriptomics in patient fibroblasts across three unrelated individuals

   PMID:37133451

   Open questions at the time

   • Does not establish whether destabilization reflects failed assembly versus accelerated turnover of the LSU
   • Genotype-phenotype basis for the broad severity spectrum not mechanistically explained
   • No structural model of how patient variants disrupt LSU integration
4. 2024 Low

   Reinforced MRPL39 as a bona fide OXPHOS disease gene in an independent clinical-genomic setting.

   Evidence Ultrarapid genomic sequencing with targeted functional studies in critically ill infants

   PMID:39417332

   Open questions at the time

   • Functional validation methods not detailed in the source
   • Single clinical context; adds confirmation rather than new mechanism
   • No new biochemical insight into MRPL39 function

• How MRPL39 is structurally positioned within the human LSU and the precise molecular basis by which pathogenic variants prevent its incorporation or destabilize the subunit remain unresolved.
• No experimentally validated RNA-binding or catalytic activity for the human protein
• No structural mapping of variant effects on LSU assembly
• Functional relevance of the heart-specific splice isoform untested